[ad_1]
The vaccine was reportedly given to 12 volunteers. Human trials of the coronavirus vaccine begin.
Coronavirus vaccine
Since last April 23, the supply of the BNT162 vaccine to the volunteers had begun.
It would be a procedure of the first phase of human clinical trials of this vaccine.
The coronavirus vaccine would be a job between the company and the pharmaceutical company Pfizer.
The first human trials started when Germany gave them authorization.
The most advanced tests are carried out in Germany, after the United Kingdom, which is already testing.
According to LaW, the next step will be to include 200 healthy people between the ages of 18 and 55.
The objective will be to find the appropriate dose to be able to measure the degree of efficacy.
In addition, to measure safety and immunogenicity, in order to probably have the results in June.
“We are proud to have completed the preclinical studies in Germany and to have received this important regulatory approval to start this first human trial. The speed with which we were able to move from the beginning of the program, to the regulatory authorizations to start this trial, speaks to the high level of commitment of each of those involved, ”said Ugur Sahin, CEO and co-founder of BioNTech.
The second phase would include people with a higher level of vulnerability to being infected with coronavirus.
The company also announced that they are targeting trials in the United States once permission is obtained.
MORE NEWS FROM COLOMBIA, HERE
[ad_2]
